This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Deutsches Krebsforschungszentrum, Ruprecht-Karls-Universitat Heidelberg, Universitat Heidelberg. Active years: 2019-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 159 
1 out of 64 
1 out of 34 
Years Active: 2019-2023
Title: Grant Hansman: Innovator in Norovirus Antibodies
Introduction
Grant Hansman is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for norovirus detection and treatment. With a total of 2 patents, his work is paving the way for advancements in medical diagnostics and therapeutics.
Latest Patents
Hansman's latest patents focus on binding polypeptides that specifically target norovirus capsid polypeptides. The first patent describes a binding polypeptide that binds to an epitope within the amino acid sequence corresponding to amino acids 250 to 300 of the norovirus genotype II.10 capsid polypeptide. This invention also includes a composition comprising the binding polypeptide and a carrier, which can be utilized in diagnostic and medical applications. Additionally, it encompasses kits, devices, and vaccines related to the binding polypeptide.
The second patent further elaborates on a binding polypeptide that specifically binds to the amino acid sequence W-V-N-X-F-Y-X, where X represents any amino acid, preferably Q or P, and another X represents any amino acid, preferably T or S. This invention includes a polynucleotide encoding the binding polypeptide and methods for detecting the presence of norovirus capsid polypeptides in samples. It also covers various kits, devices, and applications utilizing the binding peptide.
Career Highlights
Throughout his career, Grant Hansman has worked with prestigious institutions, including the German Cancer Research Center (Deutsches Krebsforschungszentrum) and Ruprecht-Karls-University Heidelberg. His experience in these organizations has contributed to his expertise in the field of virology and antibody development.
Collaborations
One of his notable collaborators is Anna Koromyslova, with whom he has worked on various projects related to his patents and research.
Conclusion
Grant Hansman is a prominent figure in the field of biotechnology, particularly in the development of norovirus antibodies. His innovative patents and collaborations highlight his commitment to advancing medical diagnostics and treatment options. His work continues to have a significant impact on the scientific community and public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile